We are testing a new combination therapy for patients with specific health conditions. This study aims to understand its safety and effectiveness in humans for the first time.
Health conditions and diseases that the clinical trial is designed to study and treat.
HER2 Positive Breast Cancer is a type of breast cancer characterized by the overexpression of the HER2 protein, which can lead to aggressive tumor growth. This condition may also involve advanced stages where the cancer has spread beyond the breast to other parts of the body.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.
